GoAI
Get started
Heartseed, Inc. logo

Heartseed, Inc.

219A.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥2,244

+¥15.00 · +0.67%

Aug 24, 3:30 PM JST

219A.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Headquartered in Tokyo, Japan, Heartseed, Inc. was established on November 30, 2015, by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa, and Yutaro Kasai. The company specializes in the development and advancement of cardiac regenerative medicine.

Industry
Biotechnology
Sector
Healthcare
Headquarters
JP
CEO
Keiichi Fukuda
Listed since
Jul 30, 2024
Employees
43

Market position

Volume
361.1K
1.26× average
Average volume
287.42K
Average daily volume
Market cap
51.33B JPY
Beta
0.54
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
31.8B JPY
EV / EBITDA
114.11×
Earnings yield
0.42%
Free cash flow yield
2.69%

Profitability & efficiency

Return on equity
2.16%
Return on assets
2.01%
Return on invested capital
1.99%

Financial health

Current ratio
18.48×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Operating marginNet margin
Gross, operating, and net margin trends51%-123%-297%-471%Operating margin, FY2022: -292.27%Operating margin, FY2023: -423.41%Operating margin, FY2024: -118.91%Operating margin, FY2025: 7.71%Net margin, FY2022: -283.08%Net margin, FY2023: -427.44%Net margin, FY2024: -93.03%Net margin, FY2025: 5.40%FY2022FY2023FY2024FY2025
Operating margin FY2022 -292.27%. Operating margin FY2023 -423.41%. Operating margin FY2024 -118.91%. Operating margin FY2025 7.71%. Net margin FY2022 -283.08%. Net margin FY2023 -427.44%. Net margin FY2024 -93.03%. Net margin FY2025 5.40%.

Income trends

Revenue

3.03B JPY+246.44%

Operating income

233.28M JPY+1.27B JPY

Net income

163.38M JPY+976.1M JPY
Income trends across reported periods3.48B JPY1.68B JPY−123.5M JPY−1.92B JPYRevenue, FY2022: 499.06M JPYRevenue, FY2023: 344.73M JPYRevenue, FY2024: 873.61M JPYRevenue, FY2025: 3.03B JPYOperating income, FY2022: −1.46B JPYOperating income, FY2023: −1.46B JPYOperating income, FY2024: −1.04B JPYOperating income, FY2025: 233.28M JPYNet income, FY2022: −1.41B JPYNet income, FY2023: −1.47B JPYNet income, FY2024: −812.73M JPYNet income, FY2025: 163.38M JPYFY2022FY2023FY2024FY2025
Revenue FY2022 499.06M JPY. Revenue FY2023 344.73M JPY. Revenue FY2024 873.61M JPY. Revenue FY2025 3.03B JPY. Operating income FY2022 −1.46B JPY. Operating income FY2023 −1.46B JPY. Operating income FY2024 −1.04B JPY. Operating income FY2025 233.28M JPY. Net income FY2022 −1.41B JPY. Net income FY2023 −1.47B JPY. Net income FY2024 −812.73M JPY. Net income FY2025 163.38M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022
Revenue3.03B JPY873.61M JPY344.73M JPY499.06M JPY
Gross profit3.03B JPY———
Research and development2.28B JPY1.44B JPY1.36B JPY1.57B JPY
Selling, general, and administrative36.56M JPY429.05M JPY436.52M JPY386.98M JPY
Operating expenses2.75B JPY1.87B JPY1.8B JPY1.96B JPY
Interest income5.07M JPY401K JPY48K JPY54K JPY
Interest expense136.29K JPY409K JPY746K JPY1.13M JPY
Depreciation and amortization45.44M JPY41.82M JPY7.57M JPY195K JPY
Operating income233.28M JPY−1.04B JPY−1.46B JPY−1.46B JPY
Net income163.38M JPY−812.73M JPY−1.47B JPY−1.41B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-21.26

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates58.8427.27-4.3-35.88Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q2 '26Q3 '26
Q2 2024, reported Apr 30, 2024: actual -29.34, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Sep 12, 2024: actual -16.75, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 13, 2024: actual 12.41, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 13, 2025: actual -21.52, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 12, 2025: actual 52.31, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 31, 2025: actual -20.45, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual -2.54, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual -21.26, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.07B1.38B692.02M1.67MQ1 '24No estimateQ2 '24No estimateQ4 '24No estimateQ2 '25No estimateQ4 '25No estimateQ2 '26BeatQ3 '26Miss
Q1 2024, reported Jan 31, 2024: actual 76.61M JPY, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Apr 30, 2024: actual 76.61M JPY, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 13, 2024: actual 720.4M JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 12, 2025: actual 1.92B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 31, 2025: actual 1.11B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 465M JPY, estimate 451M JPY, surprise +3.10%, Beat. Q3 2026, reported Aug 14, 2026: actual 1.96M JPY, estimate 451M JPY, surprise -99.57%, Miss.

219A.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

ETFs holding 219A.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares International Small-Cap Equity Factor ETF logoiShares International Small-Cap Equity Factor ETFISCF
Market value
426.95K
Weight
0.06%
AUM
684.58M USD
Expense ratio
0.24%
Price / 1D
$46.03+0.81%

Continue in GoAI

Research 219A.T

research.disclaimer